Literature DB >> 11061250

Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.

M R Frankel1, L B Morgenstern, T Kwiatkowski, M Lu, B C Tilley, J P Broderick, R Libman, S R Levine, T Brott.   

Abstract

BACKGROUND: Physicians are often asked to predict outcome after acute stroke. Very little information is available that can reliably predict the likelihood of severe disability or death.
OBJECTIVE: To develop a practical method for predicting a poor outcome after acute ischemic stroke.
METHODS: Data from the placebo arms of Parts 1 and 2 of the National Institute of Neurological Disorders and Stroke rt-PA [recombinant tissue plasminogen activator] Stroke Trial were used to identify variables that could predict a poor outcome, defined as moderately severe disability, severe disability, or death (Modified Rankin Scale score >3) 3 months after stroke.
RESULTS: Baseline variables that predicted poor outcome were the NIH Stroke Scale (NIHSS) >17 plus atrial fibrillation, yielding a positive predictive value (PPV) of 96% (95% CI, 88 to 100%). The best predictor at 24 hours was NIHSS >22, yielding a PPV of 98% (95% CI, 93 to 100%). The best predictor at 7 to 10 days was NIHSS >16, yielding a PPV of 92% (95% CI, 85 to 99%).
CONCLUSIONS: Patients with a severe neurologic deficit after acute ischemic stroke, as measured by the NIHSS, have a poor prognosis. During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome. These findings require confirmation in a separate study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061250     DOI: 10.1212/wnl.55.7.952

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

1.  Emergency and critical care management of acute ischaemic stroke.

Authors:  Stephen A Figueroa; Weidan Zhao; Venkatesh Aiyagari
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

2.  Better prevention of stroke through screening for atrial fibrillation.

Authors:  Martin A James; John L Campbell
Journal:  Br J Gen Pract       Date:  2012-05       Impact factor: 5.386

3.  Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale.

Authors:  Liqiong Fan; Sharon D Yeatts; Lydia D Foster; Pooja Khatri; Thomas Tomsick; Joseph P Broderick; Yuko Y Palesch
Journal:  Interv Neurol       Date:  2016-10-19

Review 4.  Hyperacute management of ischemic stroke.

Authors:  Sarah Song
Journal:  Semin Neurol       Date:  2014-02-06       Impact factor: 3.420

Review 5.  Infarct topography and functional outcomes.

Authors:  Mark R Etherton; Natalia S Rost; Ona Wu
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-27       Impact factor: 6.200

6.  Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke.

Authors:  Srikant Rangaraju; Tudor G Jovin; Michael Frankel; Wouter J Schonewille; Ale Algra; L Jaap Kappelle; Raul G Nogueira
Journal:  Stroke       Date:  2016-09-01       Impact factor: 7.914

7.  Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management Only.

Authors:  Sudhir Datar; Christopher McLouth; Patrick Reynolds
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

8.  Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.

Authors:  Narayanaswamy Venketasubramanian; Chun Fan Lee; Sherry H Young; San San Tay; Thirugnanam Umapathi; Annabelle Y Lao; Herminigildo H Gan; Alejandro C Baroque Ii; Jose C Navarro; Hui Meng Chang; Joel M Advincula; Sombat Muengtaweepongsa; Bernard P L Chan; Carlos L Chua; Nirmala Wijekoon; H Asita de Silva; John Harold B Hiyadan; Nijasri C Suwanwela; K S Lawrence Wong; Niphon Poungvarin; Gaik Bee Eow; Christopher L H Chen
Journal:  Cerebrovasc Dis       Date:  2016-11-15       Impact factor: 2.762

9.  Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.

Authors:  Carol L Moore; Mei Lu; Faiqa Cheema; Paola Osaki-Kiyan; Mary Beth Perri; Susan Donabedian; Nadia Z Haque; Marcus J Zervos
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

10.  Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients.

Authors:  M S Mouradian; A Senthilselvan; G Jickling; J A McCombe; D J Emery; N Dean; A Shuaib
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.